Form 8-K - Current report:
SEC Accession No. 0001193125-25-048529
Filing Date
2025-03-06
Accepted
2025-03-06 17:12:19
Documents
16
Period of Report
2025-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d910737d8k.htm   iXBRL 8-K 27226
2 EX-99.1 d910737dex991.htm EX-99.1 93051
7 GRAPHIC g910737g0306061058093.jpg GRAPHIC 3947
  Complete submission text file 0001193125-25-048529.txt   298396

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20250306.xsd EX-101.SCH 4247
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20250306_def.xml EX-101.DEF 13885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20250306_lab.xml EX-101.LAB 23296
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20250306_pre.xml EX-101.PRE 14853
18 EXTRACTED XBRL INSTANCE DOCUMENT d910737d8k_htm.xml XML 6202
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 25716295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)